Preparation and Characterization of Substrates
Following the general procedure, 1 the corresponding ketone (1 equiv.) and amine (1.05 equiv.) were condensed in refluxing toluene for 3 hours using a Dean-Stark trap. After cooling, three quarter of toluene was evaporated under reduced pressure and the resulting mixture was added dropwise to a solution of chloroacetyl chloride (2 equiv.) in toluene at 0 °C. After stirring the reaction for 2 hours at 0 °C, triethylamine was added dropwise at the same temperature and stirred for further 2 hours. The mixture was then quenched with a saturated solution of NaHCO3 and diluted with EtOAc. The organic phase was extracted two times with water to remove the excess of base, dried over MgSO4, filtered and concentrated under reduce pressure. Purification was performed by column chromatography using a gradient mixture of Pentane/EtO2 as eluent.
N-benzyl-2-chloro-N-(cyclohex-1-en-1-yl)acetamide (1a)
Substrate 1a was prepared following the general procedure. The product was obtained in 67% yield as a white solid. 1 H NMR (400 MHz, CDCl3) δ 7.37-7.14 (m, 5H), 5.45 (bs, 1H), 4.61 (s, 2H), 4.11 (s, 2H), 2.01 (dt, J = 6.0, 3.1 Hz, 4H), 1.77-1.60 (m, 2H), 1.59-1.45 (m, 2H); 13 C NMR (101 MHz, CDCl3) δ 165.8, 137.4, 137.1, 129.3, 128.8, 128.3, 127.4, 49.9, 41.8, 27.9, 24.7, 22.6, 21.3 . Physical data were previously reported. 1 N-benzyl-2-chloro-N-(3,6-dihydro-H-pyran-4-yl)acetamide (1b) Substrate 1b was prepared following the general procedure. The product was obtained in 63% yield as a yellow oil. 1 H NMR (400 MHz, CDCl3) δ 7. 33-7.18 (m, 5H), 5.50 (bs, 1H), 4.64 (s, 2H), 4.19-4.05 (m, 4H) , 3.78 (t, J = 5.4 Hz, 2H), 2.26-2.07 (m, 2H); 13 C NMR (101 MHz, CDCl3) δ 165.8, 136.7, 135.1, 128.7, 128.5, 127.7, 127.4, 64.7, 64.2, 49.7, 41.5, 28 165.9, 137.1, 136.3, 128.9, 128.5, 128.4, 127.5, 50.0, 41.8, 38.7, 35.4, 28.2, 28.0, 25.6 
Substrate 1d was prepared following the general procedure. The product was obtained in 44% yield as a yellow oil. 1 H NMR (600 MHz, CDCl3) δ 7.41-7.12 (m, 15H), 5.69 (t, J = 3.7 Hz, 1H), 4.58 (bs, 2H), 3.85 (s, 2H), 2.70 (s, 2H), 2.51 (t, J = 6.0 Hz, 2H), 1.94-1.82 (m, 2H); 13 C NMR (151 MHz, CDCl3) δ 166.0, 147.2, 137.5, 137.2, 128.9, 128.4, 128.3, 128.2, 127.6, 126.8, 126.3, 50.0, 44.6, 41.6, 37.3, 33 165.8, 137.1, 136.3, 128.9, 128.3, 128.2, 127.4, 50.0, 41.8, 36.3, 36.2, 32.7, 30.6, 26.5, 24.7, 21.7 N-benzyl-2-chloro-N-(3,3-dimethylcyclohex-1-en-1-yl)acetamide (1f) Substrate 1f was prepared following the general procedure. The product was obtained in 21% yield as a yellow oil. 1 H NMR (400 MHz, CDCl3) δ 7.35-7.14 (m, 5H), 5.08 (s, 1H), 4.60 (bs, 2H), 4.07 (s, 2H), 1.97 (td, J = 6.2, 1.4 Hz, 2H), 1.66 (dtd, J = 9.1, 6.2, 3.1 Hz, 2H), 1.51-1.26 (m, 2H), 0.86 (s, 6H); 13 C NMR (101 MHz, CDCl3) δ 165.6, 139.5, 136.8, 134.9, 129.1, 128.2, 127.5, 49.5, 41.7, 36.1, 32.3, 28.8, 27.7, 19.6 2937, 1658, 1403, 1229, 1155, 921, 698. N-benzyl-2-chloro-N-(5,5-dimethylcyclohex-1-en-1-yl)acetamide (1g) Substrate 1g was prepared following the general procedure. The product was obtained in 41% yield as a yellow oil. 1 H NMR (400 MHz, CDCl3) δ 7.36-7.18 (m, 5H), 5.39 (d, J = 1.6 Hz, 1H), 4.59 (s, 2H), 4.11 (s, 2H), 2.03 (dd, J = 6.2, 2.6 Hz, 2H), 1.85-1.78 (m, 2H), 1.28 (t, J = 6.3 Hz, 2H), 0.91 (s, 6H); 13 C NMR (101 MHz, CDCl3) δ 165. 8, 137.1, 136.2, 128.9, 128.3, 128.2, 127.4, 49.7, 41.7, 41.3, 34.0, 29.8, 27.9, 22.5 137.6, 137.4, 129.0, 128.6, 128.3, 127.3, 50.3, 50.0, 28.2, 24.7, 22.7, 21.6 7, 148.9, 147.5, 138.0, 131.3, 128.4, 120.6, 112.0, 111.2, 55.9, 55.9, 47.8, 41.7, 33.5, 27.6, 24.7, 22.6, 21.4 0, 165.7, 140.1, 139.0, 134.1, 132.2, 130.8, 128.9, 128.1, 127.2, 124.8, 122.0, 114.9, 114.2, 55.5, 55.4, 42.4 (2C) 3, 140.3, 135.9, 131.3, 128.1, 127.6, 127.5, 52.6, 42.4, 30.1, 25.0, 22.7, 21 3036, 2940, 1756, 1657, 1384, 1243, 1207, 1071, 918, 767, 693. N-benzyl-2-chloro-N-(4-phenylbut-1-en-2-yl)acetamide (1l) 136.7, 128.7, 128.6, 128.5, 128.2, 127.6, 126.4, 115.7, 49.4, 41.4, 35.3, 32.9 3030, 2935, 2327, 2094, 1657, 1396, 1224, 910, 723. Preparation and Characterization of Products A 10 ml flask was charged with α-chloroenamide (1 equiv.), photocatalyst (1 mol%) and n-Bu3N (2 equiv.). The flask was capped with a septum and twice evacuated and backfilled with argon. Degassed DMSO (6.5 ml, 0.02M) was added via syringe. The flask was placed in a 100 ml beaker containing a blue LEDs strip glued on the inner wall and stirred for 48 hours. After this period, the mixture was diluted with Et2O and the organic phase was extracted three times with brine, dried over MgSO4, filtered and evaporated under reduce pressure. The residue was purified by column chromatography using a mixture of Hexane/EtOAc as eluent.
cis-1-benzylhexahydro-1H-indol-2(3H)-one (2a)
The title compound was synthesized according to the general procedure employing 1a 2935, 2325, 2098, 1807, 1683, 1412, 1256, 932, 703. cis-1-benzyl-5,5-diphenylhexahydro-1H-indol-2(3H)-one (2d) The title compound was synthesized according to the general procedure 150.0, 143.9, 137.0, 128.6 (2C), 128.2, 128.0, 127.8, 127.4, 126.1, 126.0, 125.8, 55.3, 45.4, 43.9, 39.5, 39.0, 30.1, 29.9, 22 1, 136.9, 128.5, 127.9, 127.3, 55.8, 43.6, 40.6, 39.3, 38.6 (bs), 32.7, 31.81, 30.3 (bs), 28.5, 26.6, 21.6, 21.4 4, 137.1, 128.6, 127.9, 127.4, 55.2, 44.2, 34.0, 32.4, 31.4, 30.3, 29.3, 27.6, 27.4, 18.9 3, 177.1, 137.5, 137.2, 128.5, 128.5, 127.9, 127.8, 127.3, 127.2, 61.4, 54.5, 50.8, 44.2, 44.1, 42.5, 40.7, 38.9, 29.5, 27.8, 27.3, 25.9, 25.5, 24.5, 22.3, 21.5, 13.8, FT-IR νmax(ATR) cm -1 : 2927, 2864, 1682, 1429, 1271, 1078, 946, 703. cis-1-(3,4-dimethoxyphenethyl)hexahydro-1H-inden-2(3H)-one (2i)
The title compound was synthesized according to the general procedure employing 1i (0.13 mmol), 1 mol% of PC and 2 equiv. of Bu3N. Yield = 63%; dr > 50:1; 1 H NMR (400 MHz, CDCl3) δ 6. 80-6.68 (m, 3H), 3.87-3.84 (m, 1H), 3.85 (s, 3H), 3.83 (s, 3H) 3, 148.9, 147.5, 131.5, 120.6, 111.9, 111.2, 56.8, 55.9 (2C), 41.5, 37.0, 33.6, 32.5, 27.1, 26.9, 22.3, 21 2928, 2855, 2089, 1678, 1513, 1448, 1416, 1261, 1235, 1147, 1026, 807, 763. cis-1-(4-methoxyphenyl)hexahydro-1H-inden-2(3H)-one (2j)
The title compound was synthesized according to the general procedure employing 1j 157.6, 130.3, 126.0, 114.3, 59.3, 55.4, 38.1, 32.5, 27.4, 26.8, 22.5, 21.0 1, 140.9, 136.6, 128.6, 128.5, 128.1, 128.0, 127.4, 126.1, 77.3, 77.0, 76.7, 56.5, 44.2, 34.4, 30.7, 30.2, 23.9 2928, 2322, 2097, 1881, 1678, 1424, 1308, 1258, 1082, 701 . The title compound was synthesized following the reported procedure 2 : a solution of 2k dissolved in 2 ml of dry THF was added dropwise to sodium (6 equiv.) in liquid ammonia (circa 3 ml) at -78 °C. 
